METROVACESA S.A. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.65 EUR | +2.37% |
|
+6.13% | +7.05% |
| 02-28 | Transcript : Metrovacesa S.A., 2023 Earnings Call, Feb 28, 2024 | |
| 02-27 | Metrovacesa S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The company appears to be poorly valued given its net asset value.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- This company will be of major interest to investors in search of a high dividend stock.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
Weaknesses
- The company is in debt and has limited leeway for investment
- With an expected P/E ratio at 39.07 and 31.52 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Real Estate Development & Operations
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +7.05% | 1.4B | B+ | ||
| -4.77% | 23.68B | A- | ||
| -29.16% | 11.19B | B+ | ||
| +8.63% | 10.77B | - | B- | |
| -25.90% | 7.53B | - | B+ | |
| -5.56% | 7.03B | C- | ||
| -0.34% | 6.54B | C+ | ||
| +0.76% | 6.33B | A- | ||
| +14.08% | 3.64B | - | ||
| -5.23% | 3.59B | C |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- MVC Stock
- Ratings Metrovacesa S.A.
